Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei. by Kessler, Bianca et al.
Kessler, B; Rinchai, D; Kewcharoenwong, C; Nithichanon, A; Big-
gart, R; Hawrylowicz, CM; Bancroft, GJ; Lertmemongkolchai, G
(2017) Interleukin 10 inhibits pro-inflammatory cytokine responses
and killing of Burkholderia pseudomallei. Sci Rep, 7. p. 42791.
ISSN 2045-2322 DOI: 10.1038/srep42791
Downloaded from: http://researchonline.lshtm.ac.uk/3532713/
DOI: 10.1038/srep42791
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
1Scientific RepoRts | 7:42791 | DOI: 10.1038/srep42791
www.nature.com/scientificreports
Interleukin 10 inhibits pro-
inflammatory cytokine responses 
and killing of Burkholderia 
pseudomallei
Bianca Kessler1, Darawan Rinchai1, Chidchamai Kewcharoenwong1, Arnone Nithichanon1, 
Rachael Biggart2, Catherine M. Hawrylowicz3, Gregory J. Bancroft2 & 
Ganjana Lertmemongkolchai1
Melioidosis, caused by Burkholderia pseudomallei, is endemic in northeastern Thailand and Northern 
Australia. Severe septicemic melioidosis is associated with high levels of pro-inflammatory cytokines 
and is correlated with poor clinical outcomes. IL-10 is an immunoregulatory cytokine, which in other 
infections can control the expression of pro-inflammatory cytokines, but its role in melioidosis has 
not been addressed. Here, whole blood of healthy seropositive individuals (n = 75), living in N. E. 
Thailand was co-cultured with B. pseudomallei and production of IL-10 and IFN-γ detected and the 
cellular sources identified. CD3− CD14+ monocytes were the main source of IL-10. Neutralization of 
IL-10 increased IFN-γ, IL-6 and TNF-α production and improved bacteria killing. IFN-γ production 
and microbicidal activity were impaired in individuals with diabetes mellitus (DM). In contrast, IL-10 
production was unimpaired in individuals with DM, resulting in an IL-10 dominant cytokine balance. 
Neutralization of IL-10 restored the IFN-γ response of individuals with DM to similar levels observed 
in healthy individuals and improved killing of B. pseudomallei in vitro. These results demonstrate that 
monocyte derived IL-10 acts to inhibit potentially protective cell mediated immune responses against 
 B. pseudomallei, but may also moderate the pathological effects of excessive cytokine production 
during sepsis.
Burkholderia pseudomallei (B. pseudomallei) is a gram-negative bacterium that causes melioidosis. It is highly 
endemic in northeast Thailand and Northern Australia. However there are increasing reports in other regions 
such as South America, India and Malaysia1,2. In endemic areas, B. pseudomallei is isolated from soil, stagnant 
water and rice paddies3. Several clinical outcomes ranging from asymptomatic to localized infection, to fatal acute 
septicemia are associated with melioidosis4 and relapse of disease could still occur after infection and treatment3. 
Melioidosis is a major cause of septicemia-associated deaths in N.E. Thailand, with mortality rates of up to 40% 
even with current best-practice clinical management5.
Several risk factors have been associated with susceptibility to melioidosis, but diabetes mellitus (DM) is the 
most important, and reported in 60% of melioidosis patients6. The increased susceptibility to infection in indi-
viduals with DM has been attributed to reduced IL-12 and interferon gamma (IFN-γ ) production by monocytes 
and natural killer (NK) cells/T cells respectively7 in response to B. pseudomallei. Polymorphonuclear leukocyte 
(PMNs) of Thai individuals with DM also have reduced pro-inflammatory cytokine production8, and other func-
tions including phagocytosis, migration and apoptosis are also impaired9. PMNs also play an important role in B. 
pseudomallei infection in experimental models, suggesting that together, these PMNs defects are likely to contrib-
ute to the increased risk to melioidosis in individuals with DM10.
Given the spectrum of disease manifestations B. pseudomallei provokes, it is likely that the outcome of infec-
tion will be critically influenced by the balance between potentially protective pro-inflammatory responses which 
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promote bacterial killing versus the risks of immune pathology and septic shock. Studies in mice have found that 
cytokines such as IFN-γ in particular but also other pro-inflammatory cytokines such as IL-12, tumor necrosis 
factor (TNF-α ), and IL-18 are essential for resistance against B. pseudomallei since depletion of these cytokines in 
vivo, decreases survival and increases blood and tissue bacterial burden11–15. In both mice and humans, NK, CD4+ 
and CD8+ T cells are the cellular sources of IFN-γ in response to B. pseudomallei16–19. However, in other systems, 
these and other cytokines can also have a detrimental role by promoting the development of septic shock20. In 
the context of melioidosis, IFN-γ and its inducing cytokines, IL-18, IL-12 and IL-15 along with TNF-α and IL-6 
have shown to correlate with disease severity in melioidosis patients21,22. To protect against immune-pathology, 
anti-inflammatory responses (such as T helper (Th) 2/regulatory T cells (Treg) and others) are crucial to control 
excessive pro-inflammatory cytokine cascades but to date their role in melioidosis has not been addressed.
IL-10 is a potent anti-inflammatory immunosuppressive cytokine with a broad range of effects both directly 
and indirectly on innate and adaptive immunity23. It is important in dampening inflammatory responses but 
can contribute to pathogen persistence24. Several cell types can produce IL-10 but for many infections the most 
important in vivo sources are monocytes, macrophages, Tregs, Th2 T cells25 and other CD4+ T cells that produce 
both IL-10 and IFN-γ 26. In particular, macrophages produce IL-10 in a negative and positive feedback loop to 
dampen the uncontrolled inflammatory cytokine production during infection. IL-10 expression is tightly con-
trolled by IFN-γ and IL-10 itself; it can limit its own expression or positively feedback to amplify its own pro-
duction. In addition, IFN-γ can interfere with the IL-10 production pathway and block its production through 
phosphoinositide 3-kinase (PI3K)27. Increased IL-10 during infection down regulates many processes including 
IFN-γ production, which in turn reduces macrophage activation and disrupts the effective cellular response to 
clear the pathogen28. For example, in the absence of IL-10, mice infected with Mycobacterium tuberculosis have 
lower bacterial burdens and also improved protection when vaccinated with BCG29,30. However, the biology of 
IL-10 production and action in humans in the context of melioidosis is poorly understood. In acute infection 
with B. pseudomallei, IL-10 levels in plasma are clearly increased, and are greatest in non surviving patients22. 
 B. pseudomallei replicates within monocytes/macrophages and induces antigen specific T cell responses, but to 
date the cellular source and function of IL-10 has not been investigated.
In this study we investigated IL-10 cytokine responses to B. pseudomallei in cells from individuals living in the 
melioidosis endemic area in northeast Thailand. Our objectives were to investigate the major cellular sources of 
IL-10, its potential role in the regulation of cytokine production and killing of B. pseudomallei and to determine 
whether altered IL-10 responses contribute to the increased risk of melioidosis in individuals with DM.
Results
B. pseudomallei induces IL-10 and IFN-γ production in individuals living in melioidosis endemic 
area. We have previously shown that incubation of blood from healthy individuals from the melioidosis 
endemic region of northeast Thailand with B. pseudomallei results in production of pro-inflammatory cytokines 
including TNF-α , IL-6 and in particular IFN-γ in vitro17. To now compare the balance between pro and anti-in-
flammatory cytokine production, whole blood of a healthy representative seropositive donor was stimulated with 
killed B. pseudomallei or lipopolysaccharide (LPS) (a known inducer of IL-10) and 48 hours later assayed for 
IL-10 and IFN-γ production by ELISA. IL-10 and IFN-γ were produced in response to killed B. pseudomallei 
in a dose dependent manner (data not shown), with similar kinetics, which was maximal at 48 hours of culture 
(Fig. 1a). When we extended this analysis to a larger donor cohort, 53 and 62 out of 75 individuals responded 
significantly to B. pseudomallei by producing IL-10 and IFN-γ respectively, above medium control (Fig. 1b; 
p < 0.001). IL-10 from 32 individuals and IFN-γ from 53 individuals also responded to LPS above medium con-
trol (Fig. 1b; p < 0.001). Other studies have shown there is an increased pro-inflammatory response to cytomeg-
alovirus (CMV), Epstein-Barr virus (EMV) and Influenza31 with age, which may increase susceptibility to these 
infections. To determine if age affected the cytokine response to B. pseudomallei, we stratified the responses of 
the 75 donors according to age (with a range from 17 to 78 years old). We found IL-10 production in response 
to B. pseudomallei and LPS decreased with age (Fig. 1d; p < 0.0001). The highest IL-10 response was detected in 
individuals that were less than 30. Conversely IFN-γ production was not affected (Fig. 1c) by age and remained 
constant. The reduced IL-10 production in older individuals was not caused by changes in the number of total 
white blood cells, neutrophils, lymphocytes, monocytes, eosinophils and basophils (Table 1).
CD3−CD14+ monocytes are the major cellular source of IL-10 in response to B. pseudomallei. 
To identify the cellular sources of IL-10, PBMCs of seropositive healthy individuals were incubated with B. 
pseudomallei for 20 hours, then subsequently stained for cell surface phenotype markers (CD3 and CD14), and 
intracellular IL-10 and analyzed by flow cytometry. In a representative donor (Fig. 2a–c), incubation of PBMC 
resulted in clear induction of total IL-10+ cells and the majority was CD14+ cells within the monocyte gating area 
(Fig. 2a,b). In contrast, IL-10 production from CD3+ cells within the T cell gate was minimal at 20 hours and not 
significantly different in the presence of B. pseudomallei (Fig. 2c). The predominance of monocytes responding to 
B. pseudomallei for IL-10 production rather than T cells was confirmed in further 3 healthy individuals (Fig. 2d,e).
Neutralization of IL-10 increased IFN-γ and TNF-α production to B. pseudomallei. To assess 
the potential immunoregulatory effect of IL-10 on immune responses to B. pseudomallei, we first added exog-
enous recombinant human IL-10 to the cytokine induction assays described above. We observed dose depend-
ent inhibition of the IFN-γ response, with complete inhibition at 1ng/ml of IL-10 added (data not shown). 
To examine the effect of B. pseudomallei induced IL-10 in regulating pro-inflammatory cytokine production, 
neutralizing anti-IL-10 was then added to PBMCs from healthy individuals in the presence of killed bacteria. 
Addition of anti-IL-10 monoclonal antibodies (mAb) increased IFN-γ , TNF-α and IL-6 production in a dose 
dependent manner (not shown) and was also observed in all B. pseudomallei to PBMCs ratios (Fig. 3a). Increased 
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cytokine production was greatest at 48 hours but the kinetics of the effects differed according to the cytokine 
tested (Fig. 3b). Neutralization of IL-10 increased IFN-γ production predominantly at 48 hours, extended the 
total duration of the TNF-α response and increased IL-6 production at all time points. Purified monocytes 
also showed elevated TNF-α and IL-6 in response to B. pseudomallei at the same time points in the presence of 
anti-IL-10 mAb (Supplementary Fig. S1). In all 8 donors the neutralization of IL-10 also increased IFN-γ and 
TNF-α cytokine production (Fig. 4a,b). However IL-6 production only increased when IL-10 was neutralized in 
responding donors (Fig. 4c). To determine the cellular sources of the pro-inflammatory cytokines, PBMCs were 
stimulated for 24 hours with B. pseudomallei in the presence or absence of anti-IL-10 mAb; the surface markers of 
PBMCs were stained for CD3, TNF-α and IFN-γ . Flow cytometry gated on the lymphocyte population of a repre-
sentative donor (Fig. 4d) showed that IL-10 neutralization increased the frequency of IFN-γ positive CD3− cells 
from 0.05% to 0.91% and T cells (CD3+) from 0.04% to 0.26%. The frequency of TNF-α positive cells from the 
CD3− monocyte population (Fig. 4e) also increased from 16.47% to 28.38%. Taken together the findings show a 
trend that IL-10 produced in response to B. pseudomallei may suppress the ability of monocytes, NK cells and T 
cells to produce pro-inflammatory cytokines.
Figure 1. IL-10 and IFN-γ production by whole blood of healthy individuals in response to 
 B. pseudomallei. Whole blood of a healthy representative seropositive donor was incubated with killed  
B. pseudomallei (30:1 ratio) for 6, 12, 24 or 48 hours in vitro and supernatants assayed for IFN-γ and IL-10 (a). 
Whole blood of healthy seropositive donors (n = 75) was stimulated with killed B. pseudomallei (30:1 ratio) or 
10 μ g/ml of E. coli LPS and supernatants assayed for IFN-γ and IL-10 by ELISA after 48 hours in vitro (b). IFN-γ 
(c) and IL-10 (d) production in response to E. coli LPS or killed B. pseudomallei (30:1 ratio) from experiment 
performed in (b) were plotted according to the age of the individuals. The data in (b) are presented with the 
mean and the standard deviation. Statistical significance was determined using one way ANOVA and Tukey’s 
post test or Pearson correlation; ns, non significant, *p < 0.05, **p < 0.01 and ***p < 0.001.
Age groups <35 35–64 >64 P value
Number of subjects 16 37 22 —
Mean age 25.5 (4.9) 49.2 (6.3) 69.8 (4.1) —
Sex (Male/Female) 6/10 6/31 4/18 Δ 
WBC 7.4 (2.1) 6.1 (1.5) 6.0 (1.6) ns
Neutrophils 1.4 (4.4) 3.1 (1.0) 3.1 (0.8) *
Lymphocytes 2.3 (0.6) 2.4 (0.7) 2.1 (0.8) ns
Monocytes 0.4 (0.1) 0.3 (0.1) 0.3 (0.1) ns
Eosinophils 0.2 (0.3) 0.3 (0.2) 0.5 (0.4) *
Basophils 0.03 (0.01) 0.03 (0.02) 0.03 (0.02) ns
Table 1.  Demographic data of healthy individuals whole blood screening. WBC and sub-type measures 
are reported in cells × 106/ml [mean (SD)]. SD = standard deviation. Δ No effect of gender on IL-10 and IFN-γ 
response to B. pseudomallei and controls. Statistical significance was determined using one-way ANOVA; ns, 
non significant. *p < 0.05.
www.nature.com/scientificreports/
4Scientific RepoRts | 7:42791 | DOI: 10.1038/srep42791
Neutralization of IL-10 also enhances pro-inflammatory cytokine responses in individuals 
with DM. A previous study found individuals with DM in Singapore to have impaired IL-12 production that 
resulted in reduced IFN-γ responses to B. pseudomallei by PBMCs in vitro7. To determine whether individuals 
with DM in northeast Thailand also had altered cytokine responses to B. pseudomallei, the production of IFN-γ 
and IL-10 from healthy individuals and individuals with DM was compared (Supplementary Table S1). Whole 
blood was incubated with killed B. pseudomallei for 48 hours and IL-10 and IFN-γ production was determined 
by ELISA. In response to either B. pseudomallei or LPS, IFN-γ production was reduced in individuals with DM 
Figure 2. CD3− CD14+ monocytes are the main IL-10 producers in response to B. pseudomallei. PBMCs 
from healthy seropositive individuals were incubated with killed B. pseudomallei for 20 hours and, intracellular 
IL-10 versus cell surface expression of either CD3 or CD14 detected by flow cytometry. The profile (a) of one 
representative donor was gated on monocytes (b) and lymphocytes (c). d and e shows the frequency of IL-10 
producing CD3−CD14+ monocytes (d) or CD3+ lymphocytes (e) from multiple individuals (n = 4). The data 
in (d) are presented with the mean and the standard deviation. Statistical significance of killed B. pseudomallei 
versus medium alone was determined using paired T test; ns, non significant, *p < 0.05, **p < 0.01 and 
***p < 0.001.
Figure 3. Neutralization of IL-10 increases IFN-γ, TNF-α and IL-6 production in response to B. pseudomallei. 
PBMCs of one representative donor were stimulated with killed B. pseudomallei at various ratios (0.3:1, 3:1 
or 30:1) with or without the addition of anti-IL-10 mAb for 48 hours in vitro (a). Kinetics of PMBCs cytokine 
responses to killed B. pseudomallei (30:1 ratio) in the presence or absence of anti-IL-10 mAb for 6, 12, 24 
or 48 hours in vitro (b). IFN-γ , TNF-α and IL-6 in cell supernatants were measured by ELISA. The data are 
presented with the mean and the standard deviation.
www.nature.com/scientificreports/
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(Fig. 5a; p < 0.01) but IL-10 production was unimpaired in response to B. pseudomallei (Fig. 5b). The difference in 
IFN-γ responses between healthy individuals and individuals with DM was also observed when the individuals 
were also age matched, suggesting that blood glucose status and not age was the primary determinant (data not 
shown). The baseline of IL-6 production was high in individuals with DM when compared to healthy individuals 
in our PBMCs culture (Figs 4c and 6c). Neutralization of IL-10 in PBMCs from individuals with DM increased 
IFN-γ , TNF-α and IL-6 production (Fig. 6a–c). In particular, neutralization of IL-10 in individuals with DM 
restored IFN-γ responses to levels observed in healthy individuals. These observations suggest that the IL-10 is at 
least in part responsible for the impaired in vitro IFN-γ responses seen in these individuals who are most at risk 
of infection.
Neutralization of IL-10 improves phagocyte-mediated killing of B. pseudomallei in both 
healthy individuals and individuals with DM. To ask whether IL-10 could interfere with the micro-
bicidal activity of host cells to kill B. pseudomallei, PBMCs from healthy individuals and individuals with DM 
were infected with living B. pseudomallei in the presence or absence of anti-IL-10 mAb and the number of viable 
bacteria determined 24 hours later. Improved bacterial killing was observed in PBMCs treated with anti-IL-10 
prior to infection with B. pseudomallei in both healthy individuals and individuals with DM (Fig. 7a; p < 0.05 
and Fig. 7b; p < 0.001 respectively), compared to those without IL-10 neutralization. This was also observed in 
isolated monocytes (Supplementary Fig. S2; p < 0.01). In healthy individuals, the increased killing was associated 
with elevated production of IFN-γ , TNF-α and IL-6 in the presence of anti-IL-10 mAb only 6 hours after infec-
tion (Fig. 7c; p < 0.05, < 0.001, < 0.01 respectively). In individuals with DM (Fig. 7d; p < 0.001) neutralization of 
IL-10 increased TNF-α and IL-6 cytokine production but at this time point IFN-γ was not detected either in the 
presence or absence of IL-10 neutralization. Together, these results demonstrate that B. pseudomallei is a potent 
inducer of IL-10 production, which acts to regulate production of pro-inflammatory cytokines but also reduces 
the microbicidal activity of host cells against this pathogen in vitro.
Discussion
IL-10 is a potent immunomodulatory cytokine found in the serum of individuals with acute melioidosis, but 
until now its cellular source, impact on host immune functions and relationship to the increased susceptibility 
of individuals with DM to melioidosis was not known. In this study, we have shown that incubation of intact 
 B. pseudomallei with whole blood of healthy individuals living in the melioidosis endemic region of northeast-
ern Thailand induces both IFN-γ and IL-10. In contrast, this balance is skewed in favor of IL-10 production in 
Figure 4. Neutralization of IL-10 increases IFN-γ and TNF-α production by CD3+ versus CD3− cells in 
response to B. pseudomallei. PBMCs of healthy seropositive individuals (n = 8) were incubated with 10 μ g/ml 
 E. coli LPS or killed B. pseudomallei (30:1 ratio) versus medium alone and in the presence or absence of 3 μ g/ml  
of anti-IL-10 mAb. IFN-γ (a), TNF-α (b) and IL-6 (c) production was measured by ELISA from collected 
supernatant after 48 hours in vitro. Each symbol represents data from an individual. The values from the same 
individual in the presence or absence of anti-IL-10 mAb condition are joined by a line. To identify the cellular 
source of cytokines, PBMCs were incubated with killed B. pseudomallei (30:1 ratio) for 20 hours and assayed 
by flow cytometry for intracellular IFN-γ and TNF-α versus cell surface expression of CD3. A profile of one 
representative donor, gated initially on lymphocytes (d) and monocytes (e) by FSC/SSC shows the frequency of 
IFN-γ and TNF-α producing cells respectively. Statistical significance was determined using paired T test; ns, 
non significant, *p < 0.05, **p < 0.01 and ***p < 0.001. IL-6 statistical significance was determined from 3 out of 
6 responding donors.
www.nature.com/scientificreports/
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individuals with DM who are most at risk of infection. The functional consequences of this monocyte derived 
IL-10 response in both donor groups is to impair production of the pro-inflammatory cytokines IFN-γ , TNF-α 
and IL-6, and to reduce the killing of B. pseudomallei by host phagocytes.
Acute presentation with signs of pneumonia, bacteremia and septic shock are the most common and seri-
ous manifestations of human melioidosis5. Analysis of serum cytokine expression in these patients has shown 
increased concentrations of both pro-inflammatory cytokines, including IFN-γ , TNF-α , IL-6 and the immu-
noregulatory cytokine IL-1021,22, with expression of the latter two cytokines an independent predictor of mor-
tality22. Here, we found that incubation of human peripheral blood from healthy seropositive individuals from 
the melioidosis endemic region of N.E. Thailand resulted in the increased expression of the same cytokines in a 
dose and time dependent manner in vitro. The magnitude of our response was similar to that observed with other 
established inducers of IL-10 secretion, and is consistent with previous reports of immune cell activation by either 
live or killed whole B. pseudomallei or B. pseudomallei derived LPS via a TLR-dependent process3,32–34. The mag-
nitude of response in human samples may vary between individuals however we were able to show a similar trend 
in cytokine response in this population. However some studies in mice infected with B. pseudomallei have found 
no increase in IL-10 production14,35 whereas other studies using live B. pseudomallei18 or earlier time points12 were 
able to detect IL-10 along with other pro-inflammatory cytokines in response to infection.
Previous studies using other intracellular bacteria such as L. monocytogenes and M. tuberculosis, which share 
some common features in intracellular location and pathology with B. pseudomallei, found marginal zone B cells 
and macrophages to be the major sources of IL-10 respectively. Here, flow cytometric analysis of human PBMCs 
incubated with live B. pseudomallei showed CD3−CD14+ monocytes to be the main IL-10 producing cells from 
6 to 20 hours of culture. In contrast, CD3+ T cells were not a substantial source of IL-10 under these conditions, 
despite the fact that all blood donors had evidence of adaptive immune responses to B. pseudomallei antigens by 
serology and the presence of antigen specific, IFN-γ secreting T cells at this time17. The magnitude in response in 
this low cohort of samples was able to significantly identify the main cellular source of IL-10. However additional 
samples may be added to confirm this finding. Nonetheless our result is consistent with our evidence to date that 
natural exposure to B. pseudomallei primarily induces a Th1 oriented T cell response, and suggests there is little or 
no expression of Th2, IL-10+ Treg or dual IFN-γ ++ /IL-10+ T cells in these individuals.
In other systems, IL-10 is known to inhibit many cell mediated immune responses which are involved in 
protection against intracellular pathogens23,36,37. IL-10 suppresses macrophage and dendritic cell (DC) functions, 
including intracellular pathogen killing and production of IL-12, TNF-α and IFN-γ required for effective Th1 
responses38, each of which have been shown to be involved in immunity to B. pseudomallei either in animal mod-
els or in humans. Here, direct addition of rIL-10 to human PBMCs in the presence of B. pseudomallei reduced pro-
duction of IFN-γ in a dose dependent manner, with complete inhibition of this response at IL-10 concentrations, 
which were found both in cell culture and in the serum of infected patients. Furthermore, neutralizing endoge-
nous IL-10 in co-cultures of PBMCs with B. pseudomallei increased the production of IFN-γ , TNF-α and IL-6 in 
the majority of individuals tested. Thus, IL-10 produced during the innate immune response to B. pseudomallei 
Figure 5. IFN-γ production in response to B. pseudomallei is reduced in individuals with DM. Whole 
blood of healthy seropositive individuals (n = 75) and individuals with DM (n = 11) were incubated with 
killed B. pseudomallei (30:1 ratio), 10 μ g/ml of E. coli LPS or medium alone and culture supernatants assayed 
for IFN-γ (a) and IL-10 (b) by ELISA after 48 hours in vitro. The data are presented with the mean and the 
standard deviation. Statistical significance was determined by Mann-Whitney test; ns, non significant, *p < 0.05, 
**p < 0.01 and ***p < 0.001.
www.nature.com/scientificreports/
7Scientific RepoRts | 7:42791 | DOI: 10.1038/srep42791
actively regulates the pro-inflammatory cytokine response of the host. TNF-α is an important regulator of cell 
migration and inflammation in other bacterial infections, and mice depleted of TNF-α by neutralizing mAb 
in vivo have increased susceptibility to B. pseudomallei11. The direct contribution of IL-6 in melioidosis is not 
known but in addition to being a key component of the acute phase response, IL-6 can regulate recruitment 
and stimulation of neutrophils39, which are a crucial first line of defense during melioidosis9. Perhaps most 
importantly for control of bacterial replication, the IFN-γ response to B. pseudomallei seems to be particularly 
sensitive to down regulation by endogenous IL-10. IFN-γ is the primary cytokine responsible for activation of 
macrophages for the respiratory burst oxygen dependent killing of B. pseudomallei by macrophages40. Both NK 
cells and CD3+ T cells are important sources of IFN-γ in mice and humans following exposure to B. pseudomallei, 
and IFN-γ KO mice are exquisitely susceptibly to experimental melioidosis11,17. Here, IL-10 depletion in vitro 
increased IFN-γ production by both NK cells and CD3+ T cells, leading to a 10-fold increase in total IFN-γ pro-
duction with more rapid kinetics allowing significant production of IFN-γ by 24 hours of culture. Furthermore, 
neutralizing IL-10 in mice has also shown an increased in IFN-γ response18. Importantly, neutralization of IL-10 
additionally improved the killing of the bacterium by PBMCs and monocytes suggesting that these antimicrobial 
responses are actively down regulated by IL-10 under these conditions. Finally, IL-10 may also have other func-
tional effects on the immune response to B. pseudomallei such as expression of type I IFNs, shown to interfere 
with cytokine production and increase susceptibility to other bacterial infections41 and in the induction of pro-
gram death ligand 1 (PD-L1) expression42.
In melioidosis endemic regions, the incidence of acute infection is greatest in older individuals and in particu-
lar those with poorly controlled DM. In N.E. Thailand where our study was sited, melioidosis has been reported 
to be highest in the 55–64 age group43,44. We found IL-10 production decreased with age in response to B. pseu-
domallei and the TLR4 ligand, LPS. In contrast there was no association between age and production of IFN-γ in 
the same population. The immune responses of aging populations have mostly been studied in the context of viral 
infections, showing a heightened pro-inflammatory cytokine background in older individuals, which is suggested 
to lead to increased tissue damage31. Our study with the bacterial immune activators LPS and intact B. pseudom-
allei supports this possibility, although further studies on the susceptibility to melioidosis with age, independent 
of the confounding effect of DM in these populations, is needed.
Figure 6. Neutralization of IL-10 increases IFN-γ, TNF-α and IL-6 production in individuals with DM. 
PBMCs (n = 5) were incubated with 10 μ g/ml E. coli LPS, killed B. pseudomallei (30:1 ratio) or medium alone 
in the presence or absence of anti-IL-10 mAb. IFN-γ (a), TNF-α (b) and IL-6 (c) was measured by ELISA from 
collected supernatant after 48 hours in vitro. Each symbol represents data from an individual. The values from 
the same individual in the presence or absence of anti-IL-10 mAb are joined by a line. Statistical significance 
was determined using paired T test; ns, non significant, *p < 0.05, **p < 0.01 and ***p < 0.001.
www.nature.com/scientificreports/
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Diabetes mellitus (DM) is the strongest predisposing risk factor for developing acute melioidosis6,45. Multiple 
immune defects have been described in individual with poor glycaemic control which could contribute to this 
susceptibly, including impaired immune function especially in neutrophils, which includes phagocytosis and 
the oxidative burst9. A key study in Singapore reported that type 2 diabetics had a deficiency in intracellular glu-
tathione (GSH), which impaired production of both IL-12 and IFN-γ that led to poor control of B. pseudomallei 
replication7. Here we also observed reduced IFN-γ responses of PBMCs of Thai individuals with DM to both LPS 
and B. pseudomallei, suggesting that impairment of IFN-γ production to bacterial components is indeed a com-
mon feature of DM and may contribute to their susceptibility to a broad range of pathogens that require IFN-γ 
activated macrophages for their elimination46. In contrast, IL-10 responses were not impaired, resulting in an 
altered ratio of pro-inflammatory versus anti-inflammatory cytokine production. Importantly, neutralization of 
IL-10 in individuals with DM restored the reduced IFN-γ production to levels similar to the healthy individuals 
and increased the killing of B. pseudomallei in vitro. Although we did not detect IL-12 directly under these cul-
ture conditions, it is likely that this is mediated by changes in IL-12 since IFN-γ responses to B. pseudomallei are 
IL-12 dependent47, and IL-10 is well recognized to interfere with IL-12p35 and p40 production48,49. In summary, 
although the numbers of donors tested was not large in all assays, production of IL-10 in response to B. pseudom-
allei and increased pro-inflammatory cytokine production and bacterial killing were observed in the majority of 
individuals tested (66 out of 75 for production of IL-10, 5 out of 5 for increased IFN-γ and TNF-α secretion and 
5 out of 7 donors tested for bacterial killing). Future studies using larger sample sizes and assaying the effect of 
IL-10 neutralization on other immune functions, such as CD8+ T cells, would further strengthen our understand-
ing of the role of IL-10 in melioidosis.
In conclusion, we have shown that production of the immunoregulatory cytokine IL-10 is a prominent fea-
ture of the human innate immune response to B. pseudomallei, and actively inhibits both pro-inflammatory and 
antimicrobial responses of the host. Inhibition of the antimicrobial actions of IFN-γ , TNF-α and IL-6 are likely 
to increase the susceptibility of the host to infection. In contrast, IL-10-mediated control of excessive production 
of TNF-α and IL-6, which drive the pathological effects of the ‘cytokine storm’ found in patients with sepsis and 
septic shock may on the other hand be beneficial. Individuals with DM are most at risk of developing clinical 
melioidosis, but in contrast are less likely to die50,51. Our data showing poor IFN-γ responses but maintenance 
of IL-10 production in these individuals may help to explain these clinical findings. More detailed information 
on the effects of DM on pro-inflammatory versus immunoregulatory immune responses against B. pseudomallei 
should provide a better understanding of the pathogenesis of melioidosis and provide a basis for improved treat-
ment and prevention by vaccination.
Methods
Subjects. This study utilized peripheral blood obtained from healthy individuals versus individuals with DM 
obtained following written informed consent, and authorized by the Khon Kaen University Ethics Committee, 
research number HE470506. The study was carried out in accordance with the approved guidelines and all 
Figure 7. Neutralization of IL-10 increases the killing of B. pseudomallei by healthy individuals and 
individuals with DM. PBMCs from healthy individuals (n = 7) (a) and individuals with DM (n = 8) (b) 
were incubated with medium, live B. pseudomallei at an MOI of 1 in the presence or absence of 3 ug/ml of 
anti-IL-10 mAb for 6 hours. The number of live B. pseudomallei was assessed by colony forming unit assay. 
The cultured supernatants of healthy individuals (n = 5) (c) and individuals with DM (n = 8) (d) were assayed 
for IFN-γ , TNF-α and IL-6 by ELISA. Each symbol represents data from an individual. The values from the 
same individual in the presence or absence of anti-IL-10 mAb are joined by a line. Statistical significance was 
determined using paired T test; ns, non significant, *p < 0.05, **p < 0.01 and ***p < 0.001. Of note, cultured 
supernatants from 5 (c) out of 7 (a) healthy individuals were sufficient to be analyzed for cytokine response.
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subjects provided written informed consent. Donors attending the Khon Kaen Medical Centre, were screened 
for fasting blood sugar levels, blood pressure and their history of infections and hospitalization were determined. 
Those who had an antibody assay index to crude B. pseudomallei extract of 2 or more were considered seropos-
itive, equivalent to an indirect hemagglutination assay (IHA) of more than 40, were included in this study52. 
Measurement of serum antibodies to B. pseudomallei was performed with 96 well polystyrene plates (Nunc 
Maxisorp) either uncoated or coated with 1 μ g/ml of B. pseudomallei K96243 crude extract in 0.1 M carbonate 
bicarbonate buffer (pH 9.6) and incubated overnight at 4 °C. Plates were washed and 50 μ l/well of 1:300 diluted 
human plasma were probed in duplicates. Immunoreactivity was detected by using biotinylated-rabbit anti 
human IgG followed by horseradish peroxidase tagged with streptavidin, after incubation for 1 hour at room 
temperature. The color was developed with tetramethylbenzidine substrate (BD Biosciences) and the reaction was 
stopped with 2 N H2SO4. Optical density (O.D) of each well was read at 450 nm and the results are represented 
as absorbance index of individual sample = (O.Dtest − O.Duncoated)/O.Duncoated. Healthy individuals aged between 
17 and 78 years from Khon Kaen in the northeast region of Thailand used in this study were defined with fasting 
blood sugar of less than 126 mg/dL, normal blood pressure around 120/80 mm/Hg and had no clinical history of 
melioidosis. Individuals with DM, were defined as diagnosed with type 2 DM by a physician and fasting blood 
sugar level of more than 126 mg/dL53 at the time of blood collection. Blood samples from both groups were col-
lected, processed and assayed in parallel in the compared experiments.
Cell culture. Whole blood (WB) was collected in heparinized tubes (BD Biosciences). The total number of lym-
phocytes plus monocytes was determined using an automated machine (Sysmex) and adjusted to 1.8 × 106 cells/
ml with R10, which contains RPMI 1640 (Gibco), 10% heat inactivated fetal bovine serum (BioWest), 100 U/ml 
Penicillin/Streptomycin (Gibco), 50 μ g/ml gentamycin (Sigma), and 25 mM HEPES (Gibco). Adjusted WB 
cells were plated in duplicates onto 96 well plates (Nalgene) and incubated in the presence of Escherichia coli  
(E.coli) lipopolysaccharide (LPS) 10 μ g/ml (Sigma) or a 30:1 ratio of killed B. pseudomallei to PBMCs concentra-
tion. Killed B. pseudomallei was prepared from strain K96243 a clinical isolate from Thailand54; the whole bacteria 
were fixed with 2% paraformaldehyde for 1 hour at room temperature, washed twice with 1 × PBS (pH 7.4) and 
stored at − 80 °C. After incubation of WB with stimuli for 48 hours at 37 °C in 5% CO2, supernatant was collected 
and stored at − 80 °C for cytokine measurement by ELISA55.
In other experiments, human PBMCs were separated by density gradient centrifugation using Ficoll-Paque 
(BioWest). The PBMCs were collected and washed twice with 1 × PBS and re-suspended in R10. Cells were 
seeded at 5 × 106 cells/ml into a 96 well plate and incubated in the presence of the same conditions as the whole 
blood assay either with or without 3 μ g/ml of neutralizing anti-human IL-10 (anti-IL-10) monoclonal antibodies 
(mAb), clone JES3-19F1 (BD Biosciences) or its isotype control, clone R35-95.
Primary human monocytes were isolated from recently separated human PBMCs by positive selection using 
magnetic CD14 microbeads, according to the manufacturers instructions (Miltenyi Biotec). The CD14+ cells were 
obtained and washed with 2 mM of EDTA in 1 × PBS and re-suspended in R10. Cells were seeded at 5 × 105 cells/ml 
 into 96 well plates. Primary monocytes were treated with the same conditions as the PBMCs.
The concentration of IFN-γ , IL-10, IL-6 and TNF-α in supernatants from WB, PBMCs or isolated primary 
monocytes were measured with commercial ELISA kits (BD Biosciences) according to the manufacturers 
instructions.
B. pseudomallei killing assay. B. pseudomallei strain K96243, was grown to mid-log phase at 37 °C in 
Luria-Bertani (LB) broth and assessed by optical density at 600 nm; an absorbance index of 1 was equivalent to 
109 CFU/ml of bacteria. The PBMCs or isolated primary monocytes were treated with 10 μ g/ml of anti-IL-10 
mAb for 15 minutes prior to infection with B. pseudomallei at multiplicity of infection (MOI) of 1 and incubated 
at 37 °C for 6 hours. The supernatant was collected for cytokine analysis and the infected cells were lysed by 1% 
Triton X-100 (Biotech). The bacterial colony count was determined by standard bacterial plating on LB agar plates 
after 24 hours.
Flow cytometry for detection of intracellular cytokines. PBMCs were stimulated for 2 hours before 
3 μ g/ml Brefeldin A (Sigma Aldrich) was added; surface and intracellular cytokine staining was performed 
18 hours later. Cell surface phenotype was determined by incubating with the following mAb: anti-CD3 PerCP 
(clone UCHT1), anti-CD4 APC (clone OKT4), anti-CD14 FITC (clone MΦ P9) (BD Biosciences). Intracellular 
cytokine production was detected with anti-IFN-γ FITC (clone 4SB3), anti-TNF-α PE (clone MAb11) 
(BioLegend) and anti-IL-10 PE (clone JES3-9D7) (BD Biosciences). Isotype matched control antibodies were 
used in each analysis. Data were acquired using a FACS Caliber flow cytometer and analyzed using FlowJo version 
9.3.2 (Tree Star) with 50,000 cells acquired from either the monocytes or the lymphocytes population.
Data analysis. All data were analyzed for statistical significance using Prism 5 software (GraphPad) using 
either one way ANOVA, Tukey’s post test, Pearson correlation, paired T and Mann-Whitney test as appropriate 
to the experimental design and specified in the figure legends. P values of ≤ 0.05 were considered statistically 
significant.
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